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Abstract: 
In this paper we derive a straightforward computational approach to predict the optimal ionic liquid (IL) 
solvent for a given compound, based on COSMO-RS calculations. These calculations were performed on 
18 different active pharmaceutical ingredients (APIs) using a matrix of 240 hypothetical ILs. These results 
indicated that the 18 APIs could be classified into 3 distinct categories based on their relative hydrogen 
bond donating or accepting ability, with similar optimal IL solvent predictions within each class. 
Informed by these results, a family of strongly hydrogen bond donating ILs based on the N-
alkylguanidinium cation were prepared and characterized. The solubility of the APIs in each of these 
classes was found to be qualitatively consistent with the predictions of the COSMO-RS model. The 
suitability of these novel guanidinium salts as crystallization solvents was demonstrated by the use of N-
butylguanidinium bis(trifluoromethanesulfonyl)imide for the purification of crude fenofibrate using 
dimethylsulfoxide as an antisolvent, which resulted in good yields and excellent purities. Finally, a simple 
descriptor based model is proposed to suggest the best IL solvent for arbitrary APIs. 
Introduction: 
Ionic liquids (ILs) have attracted significant interest as solvents. ILs are commonly defined as salts that 
melt below 100 oC although many are liquid at room temperature. ILs have negligible vapor pressure 
and low flammability; properties that make them convenient to handle over a wide range of 
temperatures and process conditions.1,2 
ILs are often referred to as “designer solvents” which arises from the flexibility of cation and anion 
selection which can be used in numerous ways to tailor very specific physical and chemical properties. 
As pointed out by Crowhurst et al. 3 it is still not very clear which properties can be designed into new IL 
systems. Furthermore the term “designer solvents” is sometimes overused and often mentioned when 
the ILs studied are chosen from a small number of popular commercial ILs. Part of this is due to the lack 
of a reliable tool to aid the search and selection of new ILs. In this paper, we will demonstrate how a 
straightforward combination of computational methods results in a pragmatic model which can be 
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applied to assess the solvation properties of hypothetical new ILs. Furthermore, the present work 
demonstrates how this model played a key role in the development of new ILs.  
Despite the unique and tunable solvent properties of ILs, the research focused on exploiting these 
properties for downstream processing like purification and extraction is more limited than for 
applications as solvents for conducting chemical reactions, even though this is an essential part of all 
chemical production. A large part of the literature reporting IL separations has, until recently, mostly 
focused on a relatively narrow palate of techniques such as liquid-liquid extraction or membrane 
filtration.4–8 Reichert et al.9 discussed that the use of ILs as crystallization media is an area which has 
great potential, but has received very little attention. Some work has been conducted with an emphasis 
on the crystallization of complex molecules such as proteins10,11 or metal-organic frameworks.12  
Due to safety regulations, downstream processing requirements for the production of pharmaceuticals 
are especially stringent. Thus the separation technique must comply with very high standards for purity 
and polymorph control. Crystallization is often the preferred choice of purification technique in 
production of most Active Pharmaceutical Ingredients (APIs).13 Despite the enormous importance of 
crystallization in the chemical and pharmaceutical industry, surprisingly few studies regarding API 
crystallization in the IL literature are concerned with this matter. 
The use of ILs for the purification of APIs has not been widely investigated, with only a handful of 
literature reports.14–19 Smith et al. investigated the solubility of ibuprofen and paracetamol in two very 
similar ILs, with the only difference a subtle variation of the alkyl chain length of the imidazolium cation 
used. Both ILs featured the same hydrophobic and weakly interacting anion [PF6]
−. The scope of the 
study was to investigate the potential to use ILs in future crystallization processes of the two 
pharmaceuticals, by investigating the solubility,14 while the group in a later paper demonstrated the 
crystallization of acetaminophen from the IL.17 While these ILs are readily commercially available and 
comprise favorable properties like low viscosity, they may not a very good choice of ILs for the 
crystallization of this type of pharmaceutical, as the solubilities of most drugs are inherently low. This 
would require the use of large volumes of IL to be able to achieve industrially relevant quantities of 
crystallized API. In addition, the reactivity of the [PF6]
− anion has been reported and would be 
detrimental to their recyclability and long term use.20 An et al. demonstrated crystallizations with 
excellent polymorphic control of the API adefovir dipivoxil in similar imidazolium based ILs, however 
again with a low API/IL ratio due to the relatively low API solubility in the used ILs.18,19 At least at the 
moment ILs are still more costly than most conventionally used solvents. Thus a crystallization process 
based on IL solvents must offer a high purification capacity as well as efficient recyclability which is 
difficult if the inherent solubility of the API in the new IL solvents is low. 
That the imidazolium based ILs with weakly interacting anions are quite poor solvents for APIs in general 
was indirectly pointed out by the latter study of Azevedo.15 In their study, they examined the solubility 
of the prototype cardioactive drug LASSBio-294. They performed a qualitative analysis of hydrogen bond 
donor and acceptor sites of the drug and then showed that the solubility of the drug was primarily 
related to the hydrogen bond accepting capacity of the IL anion with alkylphosphate and acetate based 
ILs giving the greatest solubility. Furthermore, they demonstrated that the addition of even small 
amounts of water dramatically decreased the solubility, indicating these ILs may behave as useful 
solvents for conducting antisolvent crystallizations, although no actual crystallization was performed. 
These properties are analogous to the behavior of ILs studied for cellulose dissolution.21 Our group 
10.1002/chem.201605704Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
recently showed how IL mixtures based on 1-ethyl-3-methylimidazolium ([EMIM]+) acetate ([OAc]−) and 
bis(trifluoromethanesulfonyl)imide ([NTf2]
−) ILs could be applied for the purification of crude 
acetaminophen by antisolvent crystallization using a sufficiently strong hydrogen bond donating 
antisolvent, such as 1,1,1,3,3,3-hexafluoroisopropanol.16 The molar solubility of acetaminophen in the 
[EMIM][OAc]x[Ntf2]1−x mixture was found to scale linearly with the concentration of [OAc]
− anions due to 
the formation of a postulated 2:1 hydrogen bond complex. Theoretical aspects of the acetaminophen 
and IL interactions were investigated by Paluch et al. Their results suggested that the imidazolium cation 
also contributed positively to the solvating effect in acetate based ILs.22 Our group also showed that yet 
another possible strategy is to choose IL-API combinations with low solubility at room temperature by 
adopting a cooling crystallization approach.23 
Based on the studies discussed above, ILs with good hydrogen bond accepting anions are quite often 
good solvents for the APIs tested, providing a high capacity to dissolve the crude API prior to 
recrystallization.15,16 However, as we will demonstrate in our study, this reasoning cannot be applied to 
all APIs, and the IL comprising the best hydrogen bond accepting anion does not always result in high 
API solubility. Furthermore, it can be problematic to recrystallize an acidic API if the anion of the IL has 
significant Brønsted basicity. 
The COnductor-Like screening MethOd for Real Solvents (COSMO-RS)24 has successfully been 
demonstrated as a useful screening tool in several studies of solubilities in both neutral solvents and in 
ILs.25–27 COSMO-RS requires a one-time quantum mechanical calculation to generate input files 
containing the polarization surface charge, the so called σ-charge, of all solutes and solvents. Once this 
file is generated, it can be stored in a database for later use. The software then performs an analysis of 
the surface interactions between solutes and solvents using statistical thermodynamics to estimate 
activity coefficients of the solute in the solvent at infinite dilution. A detailed description of the 
individual energy terms method can be found elsewhere.24,26–29 Generally, solubilities calculated by 
COSMO-RS are correct only to within an order of magnitude and are most effective for determining 
general trends rather than absolute values. However, it should be noted that the absolute accuracy of 
the COSMO-RS method can be increased by using experimental values of parameters such as the 
enthalpy of fusion or empirical solubility points. These latter options were not used in this study owing 
to the lack of data available for many of the compounds examined. 
Unlike many other computational chemistry methods, COSMO-RS is computationally cheap and 
relatively user friendly, which makes it a more attractive tool for experimental chemists and engineers. 
As the method is so computationally cheap, it offers a significant advantage over the more high level 
approaches as it can used to map a larger landscape where hundreds or even thousands of solubility 
scenarios can be considered simultaneously. COSMO-RS is especially convenient when working with ILs 
where anions and cations are treated as individual surfaces and thus a relatively modest number of 
representative cations and anions can be systematically combined to span a large number of potential 
ILs. This makes COSMO-RS interesting to use as a prescreening tool to decide on the most useful 
solvents to choose before starting in the laboratory, where the testing of each scenario is costly both in 
terms of time and resources. 
This “matrix” or “map” approach has previously been demonstrated in a few studies for the solubility of 
biomolecules, such as cellulose27 and selected flavonoids26 as well as for the solubility of gases30–32 in ILs. 
All of these studies used an extensive number of cation and anion combinations. The main conclusion 
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that can be drawn from several of these studies was that solubility could be correlated to the hydrogen 
bond accepting capabilities of the anion, while the cations in all these specific cases played a minor role. 
In this study, we have selected 15 anions and 14 cations that intentionally span a wide range of 
hydrogen bond donor and acceptor strengths, thus estimating the solubility of each API in 240 different 
ion pairs. Furthermore, we expanded our prescreening to a large and diverse group of 18 different APIs. 
It is important to emphasize that the purpose of the theoretical study is not to predict accurate 
solubilities of each API, but to establish an overview of more global solubility trends among many 
potential solvents and many diverse APIs. The main trends predicted with the COSMO-RS calculations 
were then evaluated experimentally and their use in designing a novel antisolvent crystallization process 
were demonstrated. 
Results: 
Figure 2 shows three representative examples of the solubility profiles generated by the COSMO-RS 
calculations. The structures of the ions used and the 18 solubility maps generated can be found in the 
supporting material. The map profiles for each API were subtly different, however by examining such a 
large number of different compounds some general patterns were noted. These patterns meant that 
most of the APIs could be categorized into two main types, denoted; hydrogen bond donating (HBD) and 
hydrogen bond accepting (HBA) APIs, the classification of which will be discussed below. Some APIs 
possessed significant properties from both groups and these have been denoted hybrids. The 
categorization of the 18 APIs investigated is shown in Figure 1 
 
Figure 1 - An overview of all the different APIs used in the study and their classification as outlined in the text.  
 
 
 
10.1002/chem.201605704Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
 Figure 2- Three solubility maps showing estimated solubilities, as given by their reciprocal activity coefficient at infinite dilution, 
in 240 different ion combinations calculated by COSMO-RS. Structures of the ions and their abbreviations can be found in the 
supporting information. Red squares corresponds to predicted high solubilities, whereas blue correspond to very low predicted 
solubilities. The tree maps shows representative profiles for APIs belonging to either HBD (acetaminophen), HBA (Griseofulvin) or 
hybrid (Cimetidine). The solubility maps for the remaining 15 APIs investigated can be found in the supporting information. 
Compounds that we have denoted HBD API’s generally comprise both hydrogen bond donating and 
accepting sites, but their solubility is governed primarily by their hydrogen bond donating 
characteristics. The solubility of this group of APIs is dominated by the hydrogen bond accepting 
properties of the anion. Hence the best choice of solvent in terms of API solubility would be a good 
hydrogen bond accepting anion such as [OAc]−. Similar trends were predicted and shown by Azevedo et 
al. for a single API that would be classified as HBD under this scheme.15 APIs that have been classified as 
HBD include albuterol, amoxicillin, aspirin, ibuprofen, naproxen and triclabendazole. 
In contrast to the existing literature which suggests ILs with strong hydrogen bond accepting anions are 
often the solvents with highest capacity for many APIs, a rather large group of APIs were found where 
the calculations suggested that such ILs would not be good solvents. We have denoted these HBA APIs. 
The HBA APIs include etomidate, ciprofloxacin, fenofibrate, griseofulvin, itraconazole and azithromycin. 
A main feature of the COSMO-RS results was that they showed the HBA APIs comprised very few or no 
accessible sites capable of hydrogen bond donation. These APIs represent a significant proportion of 
those studied, including several for which poor solubility is a common challenge both in their production 
as well as final application.  
In some cases, HBA APIs simply lack hydrogen bond donor groups, for example griseofulvin, fenofibrate 
or itraconazole. In other cases, such as azithromycin, the hydrogen bond donor groups of the molecule 
were engaged in strong intramolecular hydrogen bonds with acceptor groups on the same molecule 
resulting in the overall cancelation of the net hydrogen bond donor capabilities. 
For HBA APIs, the best solvent type in the matrix was the quite unusual combination of a strong 
hydrogen bond donating cation and a very weakly interacting anion. This type of IL is not commonly 
represented among commercial ionic liquids. In our hypothetical prescreening matrix, this combination 
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was represented by an unsubstituted guanidinium cation combined with the [PF6]
− anion. This “red 
point” quite early in the study caught our attention as quite unusual because the cation plays the major 
role in the solubility, whereas the identity of the cation is normally considered less important than that 
of the anion regarding solute solubility. Where cation effects are implicated, it is often argued in terms 
of π-π or ion-π effects in the case of aromatic solute-solvent reactions, or through indirect effects such 
as the influence of the cation on cation–anion association and the ability of the anion to solvate the 
solute.33 Interestingly, even ion-π effects are often only indirectly linked to the cation as these have 
been linked with weaker cation-anion interactions and often result more from anion-π rather than 
cation-π type solubilization.33,34 Part of the reason for the limited role of the cation in most systems 
studied are the relatively weak hydrogen bond donating properties of the typical cations used in ILs.35–37  
More closely examining the σ-charge of the combination of a unsubstituted guanidinium cation and the 
[PF6]
− anion, calculated during the COSMO quantum mechanical calculations, suggests a more strongly 
hydrogen bond donating cation than is typically observed. The surfaces colored according to the σ-
charge, denoted the σ-surface, provide an intuitive tool to understand the hydrogen bonding of both 
solutes and solvents. Additionally, the amount of surface area as a function of a specific surface charge 
density can be illustrated by what are known as σ-plots. Selected σ-surfaces and their σ-plots from this 
study are compared in Figure 3. From the right figure it is noticeable that the guanidinium ion is an 
excellent hydrogen bond donor, much better than the 1-alkyl-3-methylimidazolium ILs that are normally 
counted among the best hydrogen bond donating ILs.35,37 The σ-plot also shows that the [PF6]
− anion is 
an exceptionally poor acceptor, making the hypothetical [Gun][PF6] a strong hydrogen bond donor. 
Hence [Gun][PF6] makes an excellent choice as a high capacity solvent for dissolving APIs that can only 
hydrogen bond via their hydrogen bond accepting groups, such as griseofulvin shown on the left hand 
side of Figure 3 which lacks hydrogen bond donating groups.  
  
Figure 3: σ-plots and σ-surfaces surfaces obtained from the COSMO-RS calculations. Areas with a large overall positive charge 
density are illustrated in blue, negative charge density in red and low positive and negative charge densities in green and yellow 
respectively. Low electron density regions (i.e. Hydrogen bond donating sites) are depicted in blue, while high electron density 
regions (i.e. hydrogen bond accepting sites) in red. Left: σ-plots for two representative examples of HBD and HBA APIs. Right: σ-
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plots associated with selected ions used in the calculation as well as the [NTf2]
−
 ion that will be described later in the 
experimental section.  
 
Finally, we have placed the remaining compounds into a group we calls hybrids. They all seem to have 
weak to moderate hydrogen bonding capabilities through both acceptor and donor groups. Thus the 
COSMO-RS calculations suggests that they should have reasonable solubility in the two different 
archetypical ILs presented above.  
From the purely quantum mechanical input COSMO-RS calculates several descriptors for each 
compound, called σ-moments in COSMO-RS terminology. The single value descriptors HB_don3 and 
HB_acc3 are of particular interest in in this study as they describe the aggregate hydrogen bond 
donating and accepting capacity of each compound respectively. These descriptors relate well to 
experimentally derived descriptors.38–40 Examples in the literature have shown that the descriptor 
HB_acc3 in particular is a good indicator for the success of IL solvents in the dissolution of cellulose and 
flavonoids.26,27 
Inspired by this approach we analyzed the descriptor values of archetypal HBD and HBA APIs, to see if 
these descriptors could be used to assign them to either of the two groups. As the molecules differ 
greatly in size we normalized the descriptors with respect to the cavity volume of the compound, see 
Table 1. We could observe that no clear trend could be found based on either of the two descriptors 
alone, and the group assignment seemed to rely more on the ratio between two descriptors. Thus we 
finally found that the logarithm to the ratio between HB_don3 and HB_acc3 correlated well with our 
classification system. This ratio is straightforward to calculate for APIs and, given the similarity of 
COSMO-RS results for each classification of API, makes the COSMO-RS prescreening method even more 
practical as it does not require setting up a large matrix of ions. Based on our classification system we 
found that APIs with log(HB_acc3/HB_don3) < 0 seem to belong to the HBD category, while the 
compounds with log(HB_acc3/HB_don3) > 1 belong to HBA, with intermediate values belonging to the 
Hybrid category.  
Table 1 - Overview of important key values for the different APIs used in the study. 
a)
HB_acc3 and HB_don3 descriptor values 
taken from COSMOtherm calculations. As the descriptors are size dependent, these are normalized with respect to the volume of 
the cavity and are given in 10
−2
Å
-3
. Where relevant, the pKa values are also given. Unless otherwise stated all melting points and 
pKa values are experimental and are taken from 
41,42
 and references herein. 
b)
Non-Steroidal Anti-Inflammatory Drug 
API log(HB_acc3/HB_don3
) 
Classific
ation 
PKa Relative 
HB_acc3 
a
 
Relative 
Hb_don
3 
a
 
MP 
(°C) 
API use 
Acetaminophen -0.11 HBD 9.9 2.39 3.10 170 Pain reliever 
and fever 
reducer 
Albuterol -0.10 HBD 9.3 1.63 2.07 148 Asthma 
Amoxicillin -0.10 HBD 2.4 1.23 1.56 194 Antibiotic 
Aspirin -0.37 HBD 3.5 0.83 1.97 135 NSAID
 b)
 
Ibuprofen -0.45 HBD 5.2 0.49 1.37 76 NSAID
 b)
 
Triclabendazole -0.46 HBD - 0.36 1.06 176 Anthelmintics 
Naproxen -0.37 HBD 4.2 0.58 1.38 153 NSAID
 b)
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Indomethacin -0.12 HBD 4.5 0.75 0.99 151 NSAID
 b)
 
Rufinamide 0.35 Hybrid - 1.71 0.77 239 Anticonvulsant 
Cimetidine 0.35 Hybrid 6.8  2.44 1.09 142 Histamine H2-
receptor 
antagonist 
Gliclazide 0.58 Hybrid 5.8
43
 0.79 0.21 180 Hypoglycemic 
Prednisone 0.54 Hybrid - 2.06 0.60 233 Corticosteroid 
Azithromycin 1.37 HBA - 1.28 0.06 114 Antibiotic 
Ciprofloxacin 1.82 HBA 6.09 1.76 0.03 256 Antibiotic 
Etomidate 2.27 HBA - 2.08 0.01 142 Anesthetic 
agent 
Fenofibrate 2.02 HBA - 0.72 0.01 80 Cholesterol 
reducing 
Griseofulvin 1.36 HBA - 1.54 0.07 220 Antifungal 
Itraconazole 1.65 HBA - 1.27 0.03 166 Antifungal 
 
To experimentally verify that the COSMO-RS predictions were accurate, it was necessary to investigate 
the synthesis of representative guanidinium based ILs. Unfortunately, not all ion combinations in the 
matrix are ILs – in fact a lot of the combinations are salts melting at high temperatures. On this basis 
several of the good candidates could be eliminated. Initially the promising [Gun][PF6] was synthesized 
and found to have a high melting point. Initially attempts were made to prepare mixtures with 
[EMIM][NTf2] but they were unsuccessful as the guanidinium salt decomposed on dissolution. The anion 
on the guanidinium salt was then replaced by [NTf2]
− which is also weakly interacting like [PF6]
− (see 
Figure 3) but is more stable and tends to form salts with lower melting points. The resultant salt, 
[Gun][NTf2], was synthesized and melted around 90-95 
oC, which is not convenient for a recrystallization 
medium in an industrial downstream process. In order to further reduce the melting point, an alkyl side 
chain was introduced on the cation and the ethyl-, propyl- and butylguanidinium analogs were prepared 
(denoted [EtGun]+ ,[PrGun]+ and [BuGun]+ respectively, Figure 4). While [EtGun]+ was available 
commercially, [PrGun]+ and [BuGun]+ cations could be synthesized from the reaction of the 
corresponding the alkylamine with O-methyl-isourea sulfate in water.44 
 
Scheme 1. Synthesis of alkylguanidinium salts. 
This simple route avoids the many complex synthesis steps and the consequently high E-factor often 
associated with guanidinium derivative synthesis. The corresponding [NTf2]
− salts could then be 
prepared by the addition of aqueous Li[NTf2] to an aqueous solution of the alkylguanidinium sulfate salt, 
with the alkylguanidinium [NTf2] separating from the aqueous phase. Washing the IL phase, or the IL 
dissolved in dichloromethane, with water enabled the removal of residual sulfate anions and the 
isolation of the pure alkylguanidinium [NTf2] salt.  
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Figure 4 – The structure of the guanidinium [NTf2]
−
 based ILs and their abbreviations. 
 
This synthetic approach turned out to be successful with good to excellent yields resulting for the 
[PrGun][NTf2] and [BuGun][NTf2]. The yield was much lower for [Gun][NTf2] and [EtGun][NTf2] due to 
their higher aqueous solubility. An interesting aspect is that while this synthesis procedure is a 
convenient, however slightly expensive synthesis on a lab scale, a much cheaper and equally simple 
synthesis using S-methyl-isourea could be used to produce the IL on an industrial scale.44 The melting 
points of the resultant ILs decreased with increasing alkyl chain, with [BuGun][NTf2] being liquid at room 
temperature (Table 2). 
Table 2 - The melting points of the synthesized [RGun][NTf2] ILs. 
Ionic liquid Melting point 
[Gun][NTf2] >90
oC 
[EtGun][NTf2] 81
oC 
[PrGun][NTf2] 39
oC 
[BuGun][NTf2] 18
oC 
 
The use of guanidinium derived ILs is not entirely new, and different highly N-substituted ILs are 
described in several studies and references therein.36,45–49 . Highly substituted guanidine/alcohol 
mixtures has also been used in switchable solvent systems, which reversible transforms into ionic liquids 
upon addition of CO2 
50.  
However the highly substituted guanidinium ions have very different properties from those with a low 
degree of substitution presented in our study. Depending on the anion used as well as the method used 
for their characterization, studies have shown hexaalkylguanidinium based ILs either behave similarly to 
analogous imidazolium based ILs,36,46 or in other cases as significantly less polar.45 In either case these 
cations behave very differently to the monosubstituted guanidinium ILs. This seems to be a 
consequence of the changing electrostatic properties as the positive charge is dispersed over a larger 
region and the cation becomes a much poorer hydrogen bond donor due to the lack of availability of 
hydrogens directly bound to the nitrogen. 
Another well described family of guanidinium cations are those based on the tetramethyl guanidinium 
cation, which relates to the fact that tetramethylguanidine is cheap and commercially available as it is a 
widely used industrial base. Tetramethyl substituted guanidinium derived ILs and salts have been used 
as reaction media in organic synthesis,51 SO2 capture
52,53 and as electrolytes.47 
10.1002/chem.201605704Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
The new ILs we present in this work are based on singly substituted guanidinium cations, which leads 
them to possess different properties to the highly substituted ILs described above. To the best of our 
knowledge, such monoalkyl guanidinium ILs have not been described in the IL literature although there 
are a number of studies concerned with similar salts bearing different anions in the biochemistry 
literature.54–58 Monoalkylguanidines are strong Brønsted bases like guanidine,59 giving the corresponding 
guanidinium ions negligible Brønsted acidity and thus forming stable cations. As these are a new class of 
IL cation, it was of interest to compare the solvent properties of these ILs with other commonly used 
cations. Solvent polarity, particularly within ILs, is often described using the multiple parameter 
approach initially described by Kamlet and Taft.3,35,37,60The Kamlet-Taft parameters α, β and π* refer to 
the hydrogen bond acidity, hydrogen bond basicity and dipolarity and polarizability of the solvent 
respectively. These are determined experimentally through the use of solvatochromic dyes. Several 
studies have shown that these parameters correlate reasonably well with the HB_don3 and HB_acc3 
descriptors obtained computationally using COSMO-RS.38–40,61 Furthermore, several other studies have 
found that it is possible calculate other theoretical descriptors that correlate well with the Kamlet Taft 
parameters, e.g. probes in simple DFT calculations 62 or by extracting interaction energy terms from 
COSMO-RS calculations.25,63 
The HB_don3 values in Table 3 strongly suggests that [Gun]+ and [BuGun]+ cations are by far the best 
hydrogen bond donors examined, in stark contrast with the fully substituted guanidinium ILs examined. 
As this lies outside of the previous correlations conducted for α parameters, we have not attempted to 
convert this into a quantitative α value although note that it would be much higher than the 
conventionally used imidazolium ILs. This suggests that these monoalkylguanidinium ILs possess a 
similarly strong hydrogen bond donating ability as the unsubstituted guanidinium cation which they 
were synthesized to model. The same conclusion can clearly be made from the σ-profiles of selected 
cations shown in Figure 4 
 
Table 3 - HB_don3 descriptor of selected cations calculated using COSMOtherm. : 1-butyl-3-methylimidazolium [BMIM], 1-butyl-
4-methylpyridinium [BMPy], N-Ethyl-N-methylpiperidinium [EMPip], N-butyl-methylpiperidinium [BMPip], 
hexamethylguanidinium [Me6Gun], 1,1-dibutyl-2,2,3,3-tetramethylguanidinium [Bu2Me4Gun] 
IL cations HB_don3 
[Gun]+ 22 
[BuGun] + 16 
[EMIM] + 2.0 
[BMIM] + 1.9 
[BMPy] + 0.91 
[EMPip] + 0.15 
[BMPip] + 0.15 
[Me6Gun]
 + 0.0 
[Bu2Me4Gun]
 + 0.0 
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 Figure 4 – Comparison of σ-profiles of selected cations. 
 
Having prepared [BuGun][NTf2] as a good representative for the hypothetical [Gun][PF6] IL used in the 
COSMO-RS calculations, the predictions of the COSMO-RS screening study were investigated by 
measuring the experimental solubility of the APIs (Figure 5). The sequence of the APIs in the plot follows 
the value of the descriptor log(HB_acc3/HB_don3) discussed previously. The most negative values for 
HBD compounds are on the top left and the highest positive values for HBA compounds on the bottom 
right. 
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 Figure 5- Experimental solubilities in wt% for [EMIM][OAc], [BuGun][NTf2] and [EMIM][NTf2] at 25
o
C measured by 
1
H-NMR. For 
some of the APIs it was not possible to measure a finite solubility, as the IL became to viscous to stir at high concentrations of 
solute. All these were above a threshold of 30 wt.% API and are denoted by a). In some cases where the solubility was below the 
limit of detection, these are denoted by b). 
Along with the new highly hydrogen bond donating IL [BuGun][NTf2], the commercially available and 
widely used [EMIM][OAc] was chosen as the archetypal strong hydrogen bond accepting IL. To exclude 
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any active solubilizing effect of either the [EMIM]+ or the [NTf2]
− ions in the two ILs above, [EMIM][NTf2] 
was chosen as a control solvent.  
The importance of the hydrogen bond accepting anion among the HBD compounds was very well 
predicted by COSMO-RS with very high solubilities of these compounds in [EMIM][OAc] with generally 
low solubilities in the other ILs. Admittedly, some of the extraordinary high solubilities in the HBD group 
would be enhanced due to deprotonation of the APIs, which is not considered in our simplified COSMO-
RS calculations. As mentioned earlier, the role of ILs with strong hydrogen bond accepting anions as 
good solvents for compounds with strong hydrogen bond donating sites is quite well established.  
The solubilities of HBA APIs behaved as predicted by COSMO-RS. The solubilities were generally low in 
[EMIM][OAc] with high solubilities observed in[BuGun][NTf2]. The control experiments with 
[EMIM][NTf2] showed that the high solubility could be predominantly related to the strong hydrogen 
bond donating [BuGun]+ cation rather than a direct role of the [NTf2]
− anion, as would be expected. 
The last group comprising APIs that were categorized as hybrids between the two groups acted as 
expected with fairly high solubilities found for both [BuGun][NTf2] and [EMIM][OAc] in most cases. The 
major exception was rufinamide which was almost insoluble in [BuGun][NTf2] but highly soluble in 
[EMIM][OAc]. Notably rufinamide was the most ‘HBD’ like of the hybrid APIs which could account for 
this behavior. These experimental solubilities indicate that the COSMO-RS screening provided an 
excellent qualitative tool for the prediction of appropriate ILs to provide high solubilities of these APIs. 
In order to assess the efficacy of the novel IL [BuGun][NTf2] as a crystallization solvent for these HBA 
APIs, fenofibrate was chosen as a model API. A major impurity in fenofibrate is the corresponding 
carboxylic acid, often called fenofibric acid (Figure 6). 
 
Figure 6 - Structures of fenofibrate and fenofibric acid. 
The antisolvent was selected based on the following criteria: 1) The antisolvent should form strong 
hydrogen bonds with the [BuGun]+ cation, hence be a good acceptor, 2) the solubility of the impurity in 
the antisolvent should be sufficiently high to prevent its coprecipitation, and 3) the antisolvent should 
preferably be a benign non-toxic solvent (FDA Class III). Dimethylsulfoxide (DMSO) turned out to fulfill all 
of the above three criteria. Ethanol as a much weaker hydrogen bond accepting solvent was chosen for 
comparison. 
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The crystallizations were performed using a 20 % wt. solution of “crude” fenofibrate (fenofibrate mixed 
with 10 wt.% fenofibric acid) in freshly dried [BuGun][NTf2]. The yield and purities were calculated from 
HPLC analysis (Table 4). The results show that the DMSO indeed induces a selective antisolvent effect 
that causes a large amount of the fenofibrate to crystallize while retaining the fenofibric acid impurity in 
solution. While the purity was very high in the crystallized product even at low DMSO ratios, the yield 
started dropping dramatically as the concentration of DMSO increased, indicating that DMSO beyond a 
certain point would start to act as a co-solvent instead of an antisolvent. Given the high yields at low 
volumes of DMSO, this implies a specific hydrogen bond complex with the [BuGun]+ cation forms to 
competitively reduce the solvation of fenofibrate. The low yield when using ethanol as antisolvent 
shows that is a much weaker hydrogen bond acceptor than DMSO. It should be noted that these 
crystallizations were conducted isothermally and have not been optimized, meaning that even greater 
yields could potentially be obtained by performing cooling antisolvent crystallizations or varying the 
temperature of the antisolvent crystallization. 
 
Table 4 - The yield and purity determined for the antisolvent crystallizations of fenofibrate in [BuGun][NTf2] at 25°C 
IL:AS ratio Purity Yield 
1IL :2 DMSO 99.4% 65.6% 
1IL :4 DMSO 99.7% 63.7% 
1IL :6 DMSO 99.8% 41.1% 
1IL :6 EtOH 99.9% 12.7% 
 
The DMSO-cation interactions were investigated using ATR-FTIR (Figure 7). Assignments of non-obvious 
spectroscopic modes and their shift were performed on the basis of DFT calculated IR spectra, which can 
be found in the supporting information. Initially the interaction between the cation and DMSO was 
probed by observing the N-H stretching region. Following the addition of the first two mole equivalents 
of DMSO a pronounced redshift of the intense νNH modes of the guanidinium cation occurs along with a 
new low wavenumber mode at around 3150 cm−1, indicating formation of strong hydrogen bonds with 
the DMSO. The band assigned to N-H hydrogen bonding with the oxygen of DMSO, corresponds very 
closely to that predicted in the DFT calculation of the DMSO complex(see ESI figures S21-S25 and S28-
S29). Beyond 2 mole equivalents the spectroscopic signature of the DMSO-[BuGun]+ complex does not 
significantly change and beyond 3 mole equivalents the changes in the spectra can exclusively be 
attributed to the dilution of the [BuGun]+-DMSO complex. This also explains why the yield of fenofibrate 
decreased at ratios of DMSO to [BuGun][NTf2] greater than 2:1, as the DMSO is no longer engaging in 
hydrogen bonding with the cation complex and hence would begin to solvate the fenofibrate. 
Spectra were also obtained of the fenofibrate-[BuGun][NTf2] solutions right after antisolvent addition, 
before any crystallization had occurred (Figure 8, right). The strongest hydrogen bond accepting site on 
the fenofibrate is the carbonyl group. The carbonyl stretch in the initial fenofibrate-[BuGun][NTf2] 
solution is observed at around 1717 cm−1 (νC=O). Upon addition of DMSO to the solution a dramatic 
blueshift in the fenofibrate νC=O band to around 1728 cm
−1 occurred. This is consistent with the 
occupation of the cation N-H sites by the stronger hydrogen bond accepting DMSO S=O oxygen, 
selectively breaking the H-bonds between the fenofibrate and the guanidinium N-H groups. At one mole 
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equivalent the exclusion of the fenofibrate carbonyl group from the guanidinium N-H was almost 
complete, indicating that one DMSO molecule is capable of stoichiometrically binding one [BuGun]+ 
cation. The blueshift in the carbonyl C=O stretching band is well supported by the DFT simulated spectra 
(see supporting information S26-S27) 
Comparing the DMSO IR results with those containing ethanol and the fenofibrate-[BuGun][NTf2] 
solution (Figure 8, left) no strong hydrogen bonding effects were observed; instead, the spectra indicate 
a competitive equilibrium between the carbonyl-cation and the ethanol-cation complexes, explaining 
why the antisolvent effect is so much weaker. This demonstrates that the hydrogen bonding in the N-
alkylguanidinium based ILs can be interrupted easily by the correct choice of antisolvent and that this 
selection should be guided by considering the molecular interactions involved not the absolute solubility 
of the solute in the antisolvent. This is conceptually similar to the approach we have examined 
previously with the use of hydrogen bond donating antisolvents to compete with HBD type solutes.16 
 
 
Figure 7 - ATR-FTIR spectra in the N-H and C-H stretching region of mixtures of [BuGun][NTf2] and DMSO at different molar 
rations from the pure IL up to a 1:12 molar dilution with DMSO. The darker tones correspond to the pure and less diluted IL 
samples. The lower light grey spectrum is pure DMSO. 
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 Figure 8 ATR-FTIR spectra comparing the antisolvent effect on the fenofibrate-[BuGun][NTf2] system by using the fenofibrate 
carboxylic stretching as a probe. The left hand side spectra show the weak effect of adding ethanol wheras the right hand side 
shows the much more profound effect of adding DMSO. 
As an interesting side note, [BuGun][NTf2] was found to dissolve precisely 1 molar equivalent of water at 
room temperature despite being immiscible with bulk water. The hydrated IL seems to possess different 
physicochemical properties to the anhydrous [BuGun][NTf2]. For example, the anhydrous IL was fully 
miscible with dichloromethane, whereas the hydrate was immiscible. This tunable solvophobicity is 
described in greater detail in the supporting information. 
 
Conclusions: 
We have demonstrated an approach to select IL solvents for the solubilisation of APIs, based on COSMO-
RS computations. Based on the analysis of 18 different APIs, all compounds exhibited one of two major 
solubility trends or aspects of both which we categorized as HBD, HBA and hybrid. HBD APIs were 
characterized by sites that were significant hydrogen bond donors, and the calculations suggested that 
the hydrogen bond acceptor capability of the IL anion was most important to ensure high solubility. HBA 
APIs were characterized by partial or complete the lack of accessible hydrogen donating sites. In this 
case the model suggested the best IL solvents comprise a strong hydrogen bond donating cation and a 
weakly interacting anion. Based on these suggestions we synthesized a new family of ILs based on N-
alkylguanidinium cations and the [NTf2]
− anion. The calculated solubility trends and the proposed 
categorization system was tested experimentally by measuring the solubilities of the 18 APIs in 
[BuGun][NTf2], [EMIM][OAc] and [EMIM][NTf2], which showed the proposed model is an effective 
predictor of optimal solvent selection. Further we have derived a useful and very simple descriptor 
log(HB_acc3/HB_don3) to classify APIs into each of the relevant categories. This descriptor can easily be 
calculated using COSMO-RS software, and should be applicable to all organic compounds, not just 
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limited to APIs, and hence could serve as a more general methodology for determining the optimal IL 
solvent for a given solute.  
The use of [BuGun][NTf2] as a solvent for the purification of fenofibrate by antisolvent crystallization was 
demonstrated. The study showed that it was possible to manipulate the hydrogen bonding in the IL by a 
rational choice of antisolvent, where the hydrogen bond donating sites of the cation could be selectively 
occupied by the addition of DMSO. The hydrogen bonding underlying the dissolution of fenofibrate as 
well as the antisolvent mechanism was elucidated by ATR-FTIR spectroscopy. The antisolvent 
crystallization experiments with DMSO resulted in fenofibrate produced in good yields and excellent 
purity. Given the solubility of APIs appears to fall into two distinct classes, albeit with some overlap 
between the two, and it appears possible to use an antisolvent with complementary hydrogen bonding 
capabilities to the IL to achieve good isothermal antisolvent crystallisation yields; these results define a 
series of straightforward rules for the selection of optimal IL solvents and antisolvents. This selection can 
be achieved on the basis of a simple and rapid computation (i.e. that of log(HB_acc3/HB_don3)) and 
should be applicable to all organic solid solutes, not necessarily just APIs. Consequently, here we have 
defined a straightforward and general methodology by which IL solvents and antisolvents can be 
selected for the purification of organic solids by crystallization. 
 
Computational: 
All COSMO-RS calculations were performed using COSMOthermX version 14 using the TZVP 
parameterization. All the ion and compounds *.cosmo files found in the COSMOlogic databases were 
used as received, while the *.cosmo files for the remaining ion and solute data were generated using the 
BP86 functional together with the TZVP basis set. Gaussian09 was applied for structure optimization and 
Gaussian03 to generate the COSMO files.   
Calculation of the vibrational modes and their IR activity was also performed using the BP86 functional 
in combination with the TZVP basis set using a scaling factor of 1.028. The simplest model that was 
found to successfully describe the experimental spectra of [BuGun][NTf2] was a cluster comprising two 
ion pairs. As the environment of the fenofibrate was probed using its C=O stretching band, an isopropyl 
2-methoxy-2-methylpropanoate fragment was used as a model in combination with the [BuGun][NTf2] 
ion-pair dimer. For complex structures the force constants were calculated at the beginning of the 
optimization. Screenshots of the optimized structures and theoretical IR spectra can be found in the 
supporting material. 
Experimental: 
Melting points were determined visually by adding a small sample of IL to a sealed vial and raising the 
temperature of a water bath in 1oC steps.  
Ionic liquid Synthesis: 
[Gun][PF6]:  
[Gun][PF6] was synthesized by refluxing [Gun]Cl (20.0 g, 0.21 mol) (Sigma-Aldrich) and KPF6 (38.5 g, 0.21 
mol) (Sigma-Aldrich) in acetone (150 mL) for 1 week. The suspension was filtered and [Gun][PF6] was 
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obtained as a white solid by evaporation of the acetone under reduced pressure. The salt still contained 
some chloride impurities (AgNO3 test), however due to its high melting point and low stability no further 
attempts were made to purify or characterize this compound.  
[Gun][NTf2]:  
[Gun]Cl (20 g, 0.21 mol) and lithium bis(trifluoromethylsulfonyl)imide (60.3 g, 0.21 mol) (Io-li-tec) were 
each dissolved in the minimal amount of water. They were then combined resulting in a waxy white 
precipitate which was washed with a small amount of water. The precipitate was purified by dissolving it 
in acetone and standing at –20 °C to facilitate precipitation of LiCl before the solid was removed by 
filtration. [Gun][NTf2] (31 g, 0.09 mol, 43 % yield) was obtained as a white solid by evaporation of the 
acetone. Some chloride impurity was observed by the formation of a slightly milky solution when testing 
with an aqueous solution of AgNO3. However, the chloride content was found to be less than 0.1% w/w 
determined gravimetrically after the quantitative precipitation with an aqueous solution of AgNO3. 
[EtGun][NTf2]: 
Bis(Ethylguanidinium) sulfate (25.4 g, 0.295 mol) (Alfa Aesar) was dissolved in a small amount of water 
and mixed with a concentrated solution containing a half molar equivalent of lithium 
bis(trifluoromethylsulfonyl)imide (42.4 g, 0.148 mol). [EtGun][NTf2] separated as colorless crystals, 
which melted upon gentle heating of the solution forming a second liquid phase with water. The 
aqueous phase was removed, and the IL phase was washed 3 times with water before being dried in 
vacuo resulting in the formation of [EtGun][NTf2] as a white solid (9.1 g, 0.0248 mol, 8.4 %) with a 
melting point of 80-81oC. The low yield seems to occur from heavy loss during the washing steps. 
No sulfate could be detected by testing with a 0.1 M BaCl2 solution. 
MS (ESI +) (m/z (%)) 88.1 ([EtGun]+, 100). (ESI −) (m/z (%)) 279.8 ([NTf2]
−, 100). 1H NMR δ (ppm) (400 
MHz, acetone-d6) 6.00-8.00 (br s, 4H, NH), 3.42 (q, 2H, 
3JHH = 7.2 Hz, CH2), 1.26 (t, 3H, 
3JHH = 7.2 Hz, CH3). 
13C{1H} NMR δ (ppm) (101 MHz, acetone-d6) 158.05 (s, NC), 121.10 (q, 
1JCF = 320 Hz, CF3), 37.51 (s, CH2), 
14.36 (s, CH3). 
19F{1H} NMR δ (ppm) −79.96 (s, CF3). 
[PrGun][NTf2] and [BuGun][NTf2] 
In a typical synthesis, the relevant alkylamine (1.05 equivalents) and 120.0 g O-methylisourea 
hemisulfate salt (Alfa Aesar 99%) were refluxed in water for 1 week to ensure complete reaction. A 
concentrated aqueous solution of an equivalent lithium bis(trifluoromethanesulfonyl)imide (≈50 wt. %) 
was added in excess to the alkylguanidinium sulfate solution under rapid stirring which resulted in the 
formation of an IL rich bottom phase. Dichloromethane was added to increase the volume of the IL 
phase and the organic phase washed with water. After three to five extractions, the ILs tested sulfate 
free by dissolving a sample of IL in a 0.1 M BaCl2 solution. The ILs were subsequently dried in vacuo to 
produce the resultant compounds as clear, colorless liquids. 
[PrGun][NTf2] (Yield 71%) (m.p. 39 °C) MS (ESI +) (m/z (%)) 102.1 ([PrGun]
+, 100). (ESI −) (m/z (%)) 279.8 
([NTf2]
−, 100). 1H NMR δ (ppm) (400 MHz, acetone-d6) 6.20-7.80 (br s, 4H, NH), 3.33 (q, 2H, 
3JHH = 7.2 Hz, 
NCH2), 1.67 (sextet, 2H, 
3JHH = 7.2 Hz, NCH2CH2), 0.96 (t, 3H, 
3JHH = 7.2 Hz, CH3). 
13C{1H} NMR δ (ppm) (101 
MHz, acetone-d6) 158.21 (s, NC), 121.06 (q, 
1JCF = 320 Hz, CF3), 44.16 (s, NCH2), 22.84 (s, NCH2CH2), 11.28 
(s, CH3). 
19F{1H} NMR δ (ppm) −79.95 (s, CF3). 
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[BuGun][NTf2] (Yield 90 %) (m.p. 18 °C) MS (ESI +) (m/z (%)) 116.1 ([BuGun]
+, 100). (ESI −) (m/z (%)) 279.8 
([NTf2]
−, 100). 1H NMR δ (ppm) (400 MHz, acetone-d6) 6.20-7.80 (br s, 4H, NH), 3.36 (q, 2H, 
3JHH = 7.2 Hz, 
NCH2), 1.63 (quintet, 2H, 
3JHH = 7.2 Hz, NCH2CH2), 1.40 (sextet, 
3JHH = 7.2 Hz, CH2CH3), 0.92 (t, 3H, 
3JHH = 
7.2 Hz, CH3). 
13C{1H} NMR δ (ppm) (101 MHz, acetone-d6) 158.15 (s, NC), 121.00 (q, 
1JCF = 320 Hz, CF3), 
42.27 (s, NCH2), 31.49 (s, NCH2CH2), 20.39 (s, CH2CH3), 13.84 (s, CH3). 
19F{1H} NMR δ (ppm) −79.94 (s, 
CF3). 
 
Single X-Ray structures of the dry and ‘wet’ [EtGun][NTf2] was performed by Dr. Peter Muller at the MIT 
single X-ray facility as described elsewhere.64 The crystal structure including the complete structural 
details are shown in the supporting information and in the attached Crystallographic Information File. 
Solubility: 
For solubility testing 1 mL of IL was transferred to a vial with API and a small rare earth Teflon coated 
magnetic stirrer. All samples were then placed in an aluminum block maintained at 25.0 oC overnight 
with stirring. If the API completely dissolved more was gradually added until the solution was saturated. 
[EMIM][OAc] could dissolve very large amounts of some of the HBD APIs until it formed a viscous clear 
solution that could no longer be stirred. In these cases, it was not practical to obtain saturation and 
determine the true solubility, as has been noted in the text. 
After a saturated solution was obtained, the IL was filtered slowly using a syringe filter (Tuffryn 0.4µm) 
and a few drops was transferred to a vial and mixed with DMSO-d6. The 
1H-NMR spectrum was obtained 
using a Bruker Avance 400 MHz spectrometer with a d1 relaxation delay of 30 s to ensure integrals were 
quantitative. The dissolved API was quantified with respect to the signals from the cation, according to a 
method described previously.16 
ATR-FTIR: 
The spectra of the supersaturated DMSO/[BuGun][NTf2]/fenofibrate mixtures were recorded 
immediately after mixing with DMSO before any crystallization occurred. This was ensured by recording 
the spectra using a Nicolet 8700 spectrometer with a liquid nitrogen cooled MCT detector on a Golden 
gate diamond ATR cell, as well as a Smiths Detection IdentifyIR diamond ATR-FTIR equipped with an 
100x video microscope of the sample areas. The video microscope on the Smiths Detection diamond 
ATR-FTIR was used to ensure that no unwanted crystallization or phase separation had occurred at the 
time of the recording. The spectra obtained on the two instruments was identical, and the high quality 
spectra of the Nicolet 8700 instrument are the ones presented. All the spectra were ATR corrected using 
the advanced ATR correction tool in OMNIC 7.  
Fenofibrate Crystallization: 
In each of the crystallization experiments [BuGun][NTf2] (2 g), which was freshly dried at 140 
oC under 
vacuum was used. Fenofibrate (0.45 g) and fenofibric acid (0.05 g) were added to the IL at room 
temperature and the resultant solution stirred until a clear solution was obtained. The antisolvent in the 
quantity given in Table 3 was then added using a high-precision pipette with stirring, and the solution 
left stirring overnight to equilibrate. The yields were calculated from the liquid phase after crystallization 
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using the High Performance Liquid Chromatography (HPLC) procedure below with the purities 
determined from HPLC analysis of the solid. 
 
HPLC: 
The HPLC instrument (Agilent 1100) was equipped with a UV diode array detector. The column used was 
a YMC-Pack ODS-A 150 × 4.6 mm i.d. column packed with 3 μm particles with 12 nm pore size (YMC 
America Inc.). The detection wavelength was set at 254 nm. The samples were analyzed using an 
isocratic method with a 30/70 water/methanol mobile phase containing 0.1% trifluoroacetic acid for 25 
mins.  
 
Acknowledgements: The authors thank Novartis for their financial support and Dr. Peter Muller at the 
MIT single X-ray facility for his services in obtaining the crystal structure of [EtGun][NTf2]. This research 
was undertaken, in part, thanks to funding from the Canada Excellence Research Chairs Program. 
(1)  Welton, T. Chem. Soc. Rev. 1999, 99, 2071–2083. 
(2)  Rogers, R. D.; Seddon, K. R. Science. 2003, 302, 792–793. 
(3)  Crowhurst, L.; Mawdsley, P. R.; Perez-Arlandis, J. M.; Salter, P. a.; Welton, T. Phys. Chem. Chem. 
Phys. 2003, 5 (13), 2790. 
(4)  Schäfer, T.; Rodrigues, C. M.; Afonso, C. a. M.; Crespo, J. G. Chem. Commun. 2001, No. 17, 1622–
1623. 
(5)  Pei, Y.; Wang, J.; Wu, K.; Xuan, X.; Lu, X. Sep. Purif. Technol. 2009, 64 (3), 288–295. 
(6)  Oppermann, S.; Stein, F.; Kragl, U. Appl. Microbiol. Biotechnol. 2011, 89 (3), 493–499. 
(7)  Kröckel, J.; Kragl, U. Chem. Eng. Technol. 2003, 26 (11), 1166–1168. 
(8)  Marques, C. F. C.; Mourão, T.; Neves, C. M. S. S.; Lima, A. S.; Boal-Palheiros, I.; Coutinho, J. a P.; 
Freire, M. G. Biotechnol. Prog. 2013, 29 (3), 645–654. 
(9)  Reichert, W. M.; Holbrey, J. D.; Vigour, K. B.; Morgan, T. D.; Broker, G. a.; Rogers, R. D. Chem. 
Commun. 2006, No. 46, 4767. 
(10)  Li, X. X.; Xu, X. D.; Dan, Y. Y.; Zhang, M. L. Crystallogr. Reports 2009, 54 (7), 1285–1288. 
(11)  Li, X.; Xu, X.; Dan, Y.; Feng, J.; Ge, L.; Zhang, M. Cryst. Res. Technol. 2008, 43 (10), 1062–1068. 
(12)  Liao, J.-H.; Huang, W.-C. Inorg. Chem. Commun. 2006, 9 (12), 1227–1231. 
(13)  Myerson, A. S. Handbook of Industrial Crystallization, 2nd ed.; Butterworth-Heinemann, 2002. 
(14)  Smith, K. B.; Bridson, R. H.; Leeke, G. a. J. Chem. Eng. Data 2011, 56 (5), 2039–2043. 
(15)  Resende de Azevedo, J.; Letourneau, J.-J.; Espitalier, F.; Ré, M. I. J. Chem. Eng. Data 2014, 59 (6), 
1766–1773. 
(16)  Weber, C. C.; Kunov-Kruse, A. J.; Rogers, R. D.; Myerson, A. S. Chem. Commun. 2015, 51, 3649–
3657. 
(17)  Smith, K. B.; Bridson, R. H.; Leeke, G. a. CrystEngComm 2014, 16 (47), 10797–10803. 
(18)  An, J. H.; Kim, W. S. Cryst. Growth Des. 2013, 13 (1), 31–39. 
10.1002/chem.201605704Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
(19)  An, J. H.; Kim, J. M.; Chang, S. M.; Kim, W. S. Cryst. Growth Des. 2010, 1010 (7), 3044–3050. 
(20)  Swatloski, R. P.; Holbrey, J. D.; Rogers, R. D. Green Chem. 2003, 5 (4), 361. 
(21)  Swatloski, R. P.; Spear, S. K.; Holbrey, J. D.; Rogers, R. D. J. Am. Chem. Soc. 2002, 134, 4974–4975. 
(22)  Paluch, A. S.; Lourenc, T. C.; Han, F.; Costa, L. T. 2016. 
(23)  Weber, C. C.; Kulkarni, S. a.; Kunov-Kruse, A. J.; Rogers, R. D.; Myerson, A. S. Cryst. Growth Des. 
2015, 15, 4946−4951. 
(24)  Klamt, A. J. Phys. Chem. 1995, 99, 2224–2235. 
(25)  Cláudio, A. F. M.; Swift, L.; Hallett, J. P.; Welton, T.; Coutinho, J. a P.; Freire, M. G. Phys. Chem. 
Chem. Phys. 2014, 16 (14), 6593–6601. 
(26)  Guo, Z.; Lue, B.-M.; Thomasen, K.; Meyer, A. S.; Xu, X. Green Chem. 2007, 9 (12), 1362. 
(27)  Kahlen, J.; Masuch, K.; Leonhard, K. Green Chem. 2010, 12 (12), 2172. 
(28)  Klamt, A.; Schüürmann, G. J. Chem. Soc. Perkin Trans. 2 1993, No. 5, 799. 
(29)  Klamt,  a. Fluid Phase Equilib. 2000, 172 (1), 43–72. 
(30)  Fallanza, M.; González-Miquel, M.; Ruiz, E.; Ortiz, A.; Gorri, D.; Palomar, J.; Ortiz, I. Chem. Eng. J. 
2013, 220, 284–293. 
(31)  Lee, B.-S.; Lin, S.-T. Chem. Eng. Sci. 2015, 121, 157–168. 
(32)  Gonzalez-miquel, M.; Talreja, M.; Ethier, A. L.; Flack, K.; Switzer, J. R.; Biddinger, E. J.; Pollet, P.; 
Palomar, J.; Rodriguez, F.; Eckert, C. A.; Liotta, C. L. Ind. Eng. Chem. Res. 2012, 51, 16066−16073. 
(33)  Pereira, J. F. B.; Flores, L. a.; Wang, H.; Rogers, R. D. Chem. - A Eur. J. 2014, 20, 15482–15492. 
(34)  Shimizu, K.; Gomes, M. F. C.; Padua, A. a H.; Rebelo, L. P. N.; Lopes, J. N. C. J. Phys. Chem. B 2009, 
113 (29), 9894–9900. 
(35)  Ab Rani, M. a; Brant,  a; Crowhurst, L.; Dolan,  a; Lui, M.; Hassan, N. H.; Hallett, J. P.; Hunt, P. a; 
Niedermeyer, H.; Perez-Arlandis, J. M.; Schrems, M.; Welton, T.; Wilding, R. Phys. Chem. Chem. 
Phys. 2011, 13 (37), 16831–16840. 
(36)  Bogdanov, M. G.; Svinyarov, I.; Kunkel, H.; Steinle, C.; Arkhipova, M.; Kantlehner, W.; Maas, G. 
Zeitschrift fur Naturforsch. - Sect. B J. Chem. Sci. 2010, 65 (7), 791–797. 
(37)  Jessop, P. G.; Jessop, D. a.; Fu, D.; Phan, L. Green Chem. 2012, 14 (5), 1245. 
(38)  Zissimos, A. M.; Abraham, M. H.; Klamt, A.; Eckert, F.; Wood, J. J. Chem. Inf. Comput. Sci. 2002, 42 
(6), 1320–1331. 
(39)  Panayiotou, C. Phys. Chem. Chem. Phys. 2012, 14 (11), 3882. 
(40)  Tsivintzelis, I.; Panayiotou, C. G. In Handbook of Surface and colloid chemistry; Birdi, K. ., Ed.; C&C 
Press, Taylour Francis Group, 2015; pp 145–198. 
(41)  Thompson, J. E. A practical Guide to Contemporary Pharmacy Practice, Thompson,.; Lippincott 
Williams and Wilkins, 2009. 
(42)  Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; 
Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. Nucleic Acids Res. 2011, 39, 1035–1041. 
(43)  Jondhale, S.; Bhise, S.; Pore, Y. AAPS PharmSciTech 2012, 13 (2), 448–459. 
(44)  Ag, D.; Ertschenk, B. E. M.; Chulz, B. E. S.; Gmbh, N. C. Ullmann’s encyclopedia of industrial 
10.1002/chem.201605704Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
chemistry; 2012; pp 175–190. 
(45)  Carrera, G. V. S. M.; Frade, R. F. M.; Aires-de-Sousa, J.; Afonso, C. a. M.; Branco, L. C. Tetrahedron 
2010, 66 (45), 8785–8794. 
(46)  Bogdanov, M. G.; Petkova, D.; Hristeva, S.; Svinyarov, I. Zeitschrift für Naturforschung. B, A J. 
Chem. Sci. 2010, 37, 37–48. 
(47)  Schlaikjer, C. R. C. Patent application EP001363345A2, 2003. 
(48)  Olivier-Bourbigou, H.; Magna, L.; Morvan, D. Appl. Catal. A Gen. 2010, 373 (1–2), 1–56. 
(49)  Gao, Y.; Arritt, S. W.; Twamley, B.; Shreeve, J. M. Inorg. Chem. 2005, 44 (6), 1704–1712. 
(50)  Phan, L.; Chiu, D.; Heldebrant, D. J.; Huttenhower, H.; John, E.; Li, X.; Pollet, P.; Wang, R.; Eckert, 
C. A.; Liotta, C. L.; Jessop, P. G. Ind. Eng. Chem. Res. 2008, 47 (3), 539–545. 
(51)  Gao, H.; Han, B.; Li, J.; Jiang, T.; Liu, Z.; Wu, W.; Chang, Y.; Zhang, J. Synth. Commun. 2004, 34 
(17), 3083–3089. 
(52)  Yu, G.; Chen, X. J. Phys. Chem. B 2011, 115 (13), 3466–3477. 
(53)  Berg, R. W.; Harris, P.; Riisager, A.; Fehrmann, R. J. Phys. Chem. A 2013, 117 (44), 11364–11373. 
(54)  Onda, M.; Yoshihara, K.; Koyano, H.; Ariga, K. 1996, 7863 (12), 8524–8530. 
(55)  Bannard, R. A. .; Casselman, A. .; Cockburn, W. F.; Brown, G. M. Can. J. Chem. 1958, 36, 1541. 
(56)  Ariga, K.; Kamino, A.; Koyano, H.; Kunitake, T. J. Mater. Chem. 1997, 7, 1155–1161. 
(57)  David, P.; Mayan, H.; Cohen, H.; Tal, D. M.; Karlish, S. J. J. Biol. Chem. 1992, 267 (2), 1141–1149. 
(58)  Salunke, D. .; Vijayan, M. Int. J. petide protein Res. 1981, 18, 348–351. 
(59)  Davis, T. L.; Elderfield, R. C. J. Am. Chem. Soc. 1932, 54, 1499–1503. 
(60)  Kamlet, M. J.; Taft, R. . J. Am. Chem. Soc. 1976, 98, 377–383. 
(61)  Abraham, M. H. Chem. Soc. Rev. 1993, 22, 73–83. 
(62)  Niedermeyer, H.; Ashworth, C.; Brandt, A.; Welton, T.; Hunt, P. a. Phys. Chem. Chem. Phys. 2013, 
15 (27), 11566–11578. 
(63)  Kurnia, K. a.; Lima, F.; Cláudio, A. F. M.; Coutinho, J. a. P.; Freire, M. G. Phys. Chem. Chem. Phys. 
2015, 17, 18980–18990. 
(64)  Dickinson, S. R.; Müller, P.; Tanski, J. M. Acta Crystallogr. Sect. E Crystallogr. Commun. 2015, 71 
(7), o523–o524. 
 
 
 
  
10.1002/chem.201605704Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
